Agilent Technologies and Callida Genomics sign licensing agreement for DNA microarray patents
"This license enhances our extensive microarray patent portfolio and furthers our ability to bring new DNA microarray solutions to the life sciences community," said Barney Saunders, vice president and general manager of Agilent's Bioresearch Solutions business. "This agreement secures access to an important set of patents derived from Dr. Radoje Drmanac, currently CSO at Callida, who conducted pioneering work in the early development of microarrays."
"We are pleased that Agilent is able to utilize our DNA microarray patents," said George Rathman, interim president, chairman and CEO of Callida Genomics. "This agreement fits nicely with our licensing strategy for non-universal probes, further validating the strength of our patent portfolio and providing us with future royalty revenue opportunities."
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.